- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04959656
Multimodal Imaging-assisted Diagnosis Model for Cervical Spine Tumors
Based on a Small Sample Deep Learning Multi-modal Image-assisted Diagnosis Model of Cervical Spine Tumors Clinical Application Research
Cervical spine tumor is a small sample of tumor disease with low incidence, great harm, and complex anatomical structure. It is very difficult to identify and classify benign and malignant cervical spine tumors clinically.
The deep learning model we constructed in the early stage has a higher accuracy rate for the image diagnosis of cervical spondylosis with a large number of cases, and a better clinical application effect, but the accuracy rate for cervical spine tumors with a small number of cases is lower. The reason may be the amount of data. With limited tasks, the traditional deep learning model is difficult to play an effective role.
Based on this, we propose to build a small sample-oriented deep learning model to assist clinicians in the diagnosis of cervical spine tumors with multimodal images, and to evaluate the benign and malignant tumors.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Beijing, Kina
- Peking University Third Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- 18-50 years old, about 300 males and females; in the orthopedics outpatient and emergency department of our hospital, the imaging scans (X-ray, CT, MR) showed no obvious abnormalities.
Exclusion Criteria:
- have had surgery before acquiring the images, Those who have cervical spine fractures, deformities, infections, etc. who cannot cooperate with imaging examinations, and those who have not signed the informed consent. The normal control group" includes about 600 patients with normal or slightly degenerated cervical spine, as a standard for training computers to recognize cervical spine structures Images and control images for detecting tumor lesions.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
---|
X-ray
This study completed the manual labeling of preoperative multi-modal images of cervical spine structures and tumor lesions.
On the normal cervical spine, six target areas were labeled: cervical spinal cord (MRI), cervical spine alignment (MRI), cervical intervertebral discs ( MRI), cervical spinal canal area (MRI), cervical cobb angle (X-ray) and cervical posterior longitudinal ligament ossification (CT).
For cervical tumor lesions, complete MR and CT as well as orthopedic, axial and coronal positions.
The label on the lateral X-ray image.
|
CT
This study completed the manual labeling of preoperative multi-modal images of cervical spine structures and tumor lesions.
On the normal cervical spine, six target areas were labeled: cervical spinal cord (MRI), cervical spine alignment (MRI), cervical intervertebral discs ( MRI), cervical spinal canal area (MRI), cervical cobb angle (X-ray) and cervical posterior longitudinal ligament ossification (CT).
For cervical tumor lesions, complete MR and CT as well as orthopedic, axial and coronal positions.
The label on the lateral X-ray image.
|
MRI
This study completed the manual labeling of preoperative multi-modal images of cervical spine structures and tumor lesions.
On the normal cervical spine, six target areas were labeled: cervical spinal cord (MRI), cervical spine alignment (MRI), cervical intervertebral discs ( MRI), cervical spinal canal area (MRI), cervical cobb angle (X-ray) and cervical posterior longitudinal ligament ossification (CT).
For cervical tumor lesions, complete MR and CT as well as orthopedic, axial and coronal positions.
The label on the lateral X-ray image.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
tumor detection
Tidsramme: 2022-2023
|
On the basis of the cervical spine structure, it is the modeling of the tumor.
The model based on weakly supervised learning recognizes the morphological features such as the size of the tumor lesion, and uses the fast-adapted meta-learning method to achieve a fast model under a small amount of training.
Optimize, and finally evaluate the benignity, borderline and malignant probability of the tumor and use it as an output.
|
2022-2023
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
cervical spine detection
Tidsramme: 2022-2023
|
Taking the postoperative pathology report of cancer patients as the audit standard, testing the sensitivity and accuracy of the model, and integrating it into a complete deep learning model.
|
2022-2023
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Studiestol: hanqiang ouyang, Peking University Third Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- IRB00006761-M2020255
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Tumor i ryggraden
-
Ono Pharmaceutical Co. LtdRekruttering
-
Huabo Biopharm Co., Ltd.RekrutteringTumor, emnerForente stater, Kina
-
Istituto Clinico HumanitasFullført
-
Fudan UniversityRekruttering
-
Bristol-Myers SquibbFullførtPan TumorForente stater, Puerto Rico, Italia, Argentina, Australia, Belgia, Canada, Chile, Danmark, Frankrike, Tyskland, Nederland, Polen, Romania, Singapore, Spania, Storbritannia
-
National Cancer Institute (NCI)RekrutteringMetastatisk Midgut Neuroendokrin Tumor | Ikke-opererbar Midgut Neuroendocrine Tumor | Metastatisk Midgut Neuroendocrine Tumor G1 | Metastatisk Midgut Neuroendocrine Tumor G2Forente stater, Canada
-
Affiliated Hospital of Nantong UniversityPåmelding etter invitasjon
-
Martin GutierrezHackensack Meridian Health; Karyopharm Therapeutics IncTilbaketrukket
-
Incyte CorporationAvsluttetSolid tumor malignitetForente stater, Frankrike, Storbritannia, Italia, Korea, Republikken, Japan, Spania, Israel, Danmark, Tyskland, Sveits
-
ARCAGY/ GINECO GROUPRoche Pharma AGFullført